The Medical Retina Center

Filter Your Results

 

News

 

From Trials to Treatment: The Value of Real-Life Evidence in…

Although randomized, controlled trials remain the gold standard for assessing the efficacy of anti-VEGF agents, real-lif…

Professor Alex Hunyor, Professor Jean-François Korobelnik, Professor Paolo Lanzetta

Polypoidal Choroidal Vasculopathy

Gregg Kokame, MD, joins Timothy Murray, MD, MBA, to discuss his talk on polypoidal choroidal vasculopathy. Dr. Kokame di…

Gregg Kokame, MD, Timothy Murray, MD, MBA

Long-term Anti-VEGF Therapy for DME

Charles Wykoff, MD, PhD, discusses his presentation on long-term anti-VEGF therapy for diabetic macular edema. Relying o…

Timothy Murray, MD, MBA, Charles C. Wykoff, MD, PhD

Predicting Response to Anti-VEGF Monotherapy

Pravin Dugel, MD, joins Timothy Murray, MD, MBA, to discuss how best to identify patients with diabetic macular edema wh…

Pravin Dugel, MD, Timothy Murray, MD, MBA

Retina News

FDA Approved First Anti-VEGF Agent for Myopic CNV The US Food and Drug Administration (FDA) approved 0.5 mg ranibizum…

Tie Fighters

The role that VEGF plays in neovascularization and vascular leakage in patients with

Aron Shapiro; David Hollander, MD; and Lisa Smith

Characterizing the White Dot Syndromes

The inflammatory chorioretinopathies, commonly termed the white dot syndromes, are a heterogeneous group of diseases…

Michael D. Tibbetts, MD; edited by Heeral R. Shah, MD, and Jordana G. Fein, MD

Pharmacologic Treatment of PDR and DME

The Diabetic Retinopathy Clinical Research Network (DRCR.net), formed in 2002, comprises approximately 400 ophthalm…

Stephen G. Schwartz, MD, MBA, and Ingrid U. Scott, MD, MPH

 

This Month's Supplements

 
 

Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

Karen Roman
Editor-in-Chief
484-581-1827
kroman@bmctoday.com

Janet Burk
Publisher
214-394-3551
jburk@bmctoday.com

About Retina Today

Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.